Category: NVIDIA Corporation

U.S. Market Slump Led by Nvidia Sparks Global Sell-Off

A sharp decline in major U.S. stock indexes, led by tech stocks like Nvidia, reverberated through Asia and Europe on Wednesday.
Japan Stocks Tumble as U.S. Market Slump Sparks Global Sell-Off

A sharp decline in major U.S. stock indexes reverberated through Asia on Wednesday, with investors still rattled by last month’s market meltdown.
WeRide, a Chinese Autonomous Driving Start-Up, Is About to Go Public

WeRide, a $5 billion software maker, is set for an I.P.O. amid geopolitical risks and a rush by Chinese automotive tech firms to raise money in the United States.
Nvidia Shares Tumble After Reports of a Chip Delay

The A.I. chip maker’s shares fell in early trading, but the stock pared some of its losses.
Takeaways From Our Investigation Into Banned A.I. Chips in China

The Times found an active trade in Nvidia chips in China despite U.S. national security restrictions, as well as unreported incidents of how the technology had been used to further defense research.
With Smugglers and Front Companies, China Is Skirting American A.I. Bans

The U.S. is trying to stop China from getting Nvidia microchips to advance its military. The private sector is fighting back.
Intel Will Cut More Than 15,000 Jobs

The Silicon Valley chip maker also reported a net loss and declining revenue in the latest quarter.
Meta’s Lesson in Allaying Wall Street’s A.I. Fears

The tech giant is doubling down on its huge spending on artificial intelligence — but not at the expense of profits.
Inside Nvidia’s $500 Billion Wipeout

The chipmaker’s stock has tumbled in recent days, a reminder that the artificial intelligence stock boom could be tough to sustain.
$3.34 Trillion

The market value on Tuesday of Nvidia, whose chips have made it possible to create A.I. systems.
Nvidia Becomes Most Valuable Public Company, Topping Microsoft and Apple

The chip maker’s stock price has jumped over the last year thanks to its stranglehold on the market for the chips needed to build A.I. systems.
How A.I. Is Revolutionizing Drug Development

In high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. But the transformation is just getting underway.